A61K 39/0208
Specific bacteria not otherwise provided for
Official title: {Specific bacteria not otherwise provided for}
A61K39/0208 (Specific bacteria not otherwise provided for) appears on 268 US grants and 407 published applications in this corpus.
Search patents in A61K- Granted patents
- 268
- Published applications
- 407
- Assignees
- 258
- Inventors
- 806
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 2 | 1 |
| 2003 | 1 | 4 |
| 2004 | 1 | 6 |
| 2005 | 0 | 7 |
| 2006 | 1 | 6 |
| 2007 | 0 | 8 |
| 2008 | 3 | 7 |
| 2009 | 5 | 18 |
| 2010 | 9 | 18 |
| 2011 | 5 | 16 |
| 2012 | 18 | 15 |
| 2013 | 6 | 18 |
| 2014 | 19 | 31 |
| 2015 | 13 | 29 |
| 2016 | 21 | 30 |
| 2017 | 23 | 32 |
| 2018 | 23 | 19 |
| 2019 | 20 | 20 |
| 2020 | 17 | 24 |
| 2021 | 12 | 18 |
| 2022 | 14 | 19 |
| 2023 | 12 | 13 |
| 2024 | 9 | 23 |
| 2025 | 14 | 11 |
| 2026 | 9 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Intracellular delivery of biomolecules to modify immune response8 Sep 2026US 12,728,163 B2Stemcell Technologies Canada Inc.
- Immune priming to accelerate/enhance immune response through administration of natural immune modulator1 Sep 2026US 12,721,889 B2ZIVO Bioscience, Inc.
- Tumor immunotherapy composition based on antigen-presenting cells activated by attenuated listeria monocytogenes, preparation method therefor and application thereof11 Aug 2026US 12,702,681 B2Shanghai RoyalTech Med CO., Ltd
- Edible vaccination against microbial pathogens4 Aug 2026US 12,697,378 B2Dalan Animal Health, Inc.
- Compositions and methods for the treatment of allergy24 Mar 2026US 12,582,679 B2Vedanta Biosciences, Inc.
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- Rhizavidin variants8 Oct 2026US 2026/0308208 A1Affinivax, Inc.
- A broadly protective prophylactic vaccine against pseudomonas aeruginosa24 Sep 2026US 2026/0284172 A1University of Kansas
- Antibodies17 Sep 2026US 2026/0273037 A1Hydrosense Ltd
- Methods of vaccine administration to salmonids30 Jul 2026US 2026/0216310 A1Zoetis Services LLC
Most cited
By later US patents
- Microemulsions with adsorbed macromolecules and microparticles125US 8,734,832 B2Novartis AG · 2014
- Immunization and/or treatment of parasites and infectious agents by live bacteria41US 8,771,669 B12014
- Compositions and methods for enhancing the immunogenicity of antigens29US 7,588,930 B2The Trustees of the University of Pennsylvania · 2009
- Non-hemolytic LLO fusion proteins and methods of utilizing same28US 8,771,702 B2The Trustees of the University of Pennsylvania · 2014
- Transgenic algae for delivering antigens to an animal27US 7,410,637 B2Phycotransgenics L.L.C. · 2008